Thymalin
Peptide ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Thymalin is a thymus-derived peptide mixture used clinically in Russia and studied for immune homeostasis and T-cell function. It is not FDA-approved in the United States and lacks large modern, independent randomized trials. Claims for immune rejuvenation should be treated as investigational.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This safety record covers a controlled, investigational, or otherwise out-of-scope substance. It remains available for reference, but it is not part of NutriStack's public supplement publication set.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Thymalin is a peptide most often used for russian clinical use for immune indications, t-cell differentiation research, immune-aging research interest. NutriStack rates the overall evidence as insufficient. A typical adult dose is No FDA-approved US dose; Russian protocols are clinician-directed and not supplement dosing, commonly taken as not recommended outside legitimate medical or research settings. This profile indexes 3 sources.
- Injection-site reaction
- Feverish feeling
- Rash
- Autoimmune flare without specialist care
- Transplant or immunosuppressive therapy without clinician approval
The bottom line
Evidence rating insufficient. Most-documented uses: russian clinical use for immune indications, t-cell differentiation research, immune-aging research interest. 3 sources indexed (1989–2020), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Thymalin is proposed to influence thymocyte differentiation, T-cell subsets, CD28 expression, and immune recovery in settings of immunosenescence or chronic disease. Because it is a peptide mixture rather than a single well-characterized US-approved drug, product consistency and clinical translation are major concerns. Immune effects may be harmful in autoimmune disease or transplant settings.3,2
Dosing & protocol.
Peptides are generally not reliably orally bioavailable unless a specific studied oral formulation is used. Human use of research-grade products is not appropriate.
What it actually costs.
Real-world pricing across three quality tiers. Assumes Laboratory Research Reagent.
Research-market pricing is not a dosing recommendation; human use is not FDA-approved unless specifically stated. Updated 2026-06-04.
Full safety detail.
Side effects
- Injection-site reaction
- Feverish feeling
- Rash
- Immune flare in susceptible users
- Unknown product-composition risk
Contraindications
- Autoimmune flare without specialist care
- Transplant or immunosuppressive therapy without clinician approval
- Pregnancy and breastfeeding
- Active cancer without oncology review1
- Use of unregulated injectable products
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Reviews & position papers
1- 1Peptide bioregulation of aging: results and prospectsKhavinson VK et al. · Biogerontology · 2010
Thymic peptide literature reviewed
Observational studies
1- 2Effect of thymalin on immunologic reactivity of patients with non-specific lung diseasesKhavinson VK et al. · Terapevticheskii Arkhiv · 1989
Cellular immune markers changed
Mechanistic & preclinical
1- 3Thymalin: Activation of Differentiation of Human Hematopoietic Stem CellsLinkova NS et al. · Bulletin of Experimental Biology and Medicine · 2020
Thymalin affected differentiation markers
Common questions.
Quick answers about Thymalin, drawn from the data on this page.
What is Thymalin?
Thymalin is a thymus-derived peptide mixture used clinically in Russia and studied for immune homeostasis and T-cell function. It is not FDA-approved in the United States and lacks large modern, independent randomized trials. Claims for immune rejuvenation should be treated as investigational.
What is Thymalin used for?
Commonly cited benefits of Thymalin include: Russian clinical use for immune indications; T-cell differentiation research; Immune-aging research interest; Not FDA-approved in the US. NutriStack rates the overall evidence as insufficient.
What is a typical dose of Thymalin?
A typical adult dose of Thymalin is No FDA-approved US dose; Russian protocols are clinician-directed and not supplement dosing. The commonly recommended form is Not recommended outside legitimate medical or research settings. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Thymalin?
Reported side effects include injection-site reaction, feverish feeling, rash, immune flare in susceptible users, unknown product-composition risk. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Thymalin?
NutriStack rates this as Insufficient, meaning the body of evidence reviewed in NutriStack's tiering framework. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Thymalin in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.